Results

Total Results: 141 records

Showing results for "nonopioid".

1. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain
   March 01, 2019 - Nonopioid Pharmacologic Treatments for Chronic Pain Timeline February 25, 2019 Topic … Initiated March 01, 2019 Research Protocol Nonopioid Pharmacologic … Treatments for Chronic Pain April 16, 2020 Systematic Review Nonopioid

2. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/research
   April 16, 2020 - Timeline Feb. 25, 2019 Topic Initiated Mar. 1, 2019 Research Protocol Apr. 16, 2020 Systematic Review Nonopioid … Purpose of Review Evaluate the benefits and harms of nonopioid drugs in randomized controlled trials … Randomized controlled trials (RCTs) of nonopioid pharmacologic agents in patients with chronic pain were … Withdrawal from study due to adverse events was significantly increased with nonopioid drugs, with the … Nonopioid Pharmacologic Treatments for Chronic Pain. Comparative Effectiveness Review No. 228.

3. Nonopioid Pharmacologic Treatments for Chronic Pain | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/protocol
   March 01, 2019 - Timeline Feb. 25, 2019 Topic Initiated Mar. 1, 2019 Research Protocol Apr. 16, 2020 Systematic Review Nonopioid … The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain recommends that nonopioid therapy is … The purpose of this report is to evaluate the effectiveness and comparative effectiveness of nonopioid … In patients with chronic pain, what is the comparative effectiveness of nonopioid pharmacologic agents … compared to other nonopioid pharmacologic agents for outcomes related to pain, function, and quality

4. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
   February 01, 2019 - Nonopioid Pharmacologic Treatments for Chronic Pain Evidence-based Practice Center Systematic … Review Protocol Project Title: Nonopioid Pharmacologic Treatments for Chronic Pain I. … The 2016 CDC Guideline for Prescribing Opioids for Chronic Pain recommends that nonopioid therapy is … The purpose of this report is to evaluate the effectiveness and comparative effectiveness of nonopioid … compared to other nonopioid pharmacologic agents for outcomes related to pain, function, and quality

5. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
   April 01, 2020 - Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary Purpose of Review Evaluate the … benefits and harms of nonopioid drugs in randomized controlled trials of patients with spe- cific types … Nonopioid Pharmacologic Treatments for Chronic Pain Evidence Summary Comparative Effectiveness Review … The most common forms of nonopioid pharmacologic treatment for pain are nonsteroidal anti- R 2 … versus other nonopioid pharmacologic agents

6. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix G (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apg.xlsx
   January 01, 2019 - Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix G Appendix G.

7. Disposition of Comments: CER 228, Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
   April 16, 2020 - Disposition of Comments: CER 228, Nonopioid Pharmacologic Treatments for Chronic Pain Comparative … Effectiveness Review Disposition of Comments Report Research Review Title: Nonopioid Pharmacologic … Nonopioid Pharmacologic Treatments for Chronic Pain. Comparative Effectiveness Review No. 228. … ASRA recognizes that all drugs – opioid and nonopioid – carry risks. … https://effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/research

8. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
   January 01, 2018 - Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 Appendix F2.

9. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
   August 08, 2017 - Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E Appendix E.

10. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

11. App-F1-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

12. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

13. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

14. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

15. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

16. App-G-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

17. App-G-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

18. App-G-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

19. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

20. App-F1-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…